References
- Mountain, C F. A new international staging system for lung cancer. Chest 1986, 89 (suppl), S225–S233.
- Kelly, K.; Crowley, J.; Bunn, P A., Jr.; , et al. Randomized phase III trial of paclitaxel plus carboplatin versus vinorelbine plus cisplatin in the treatment of patients with advanced non-small-cell lung cancer: a Southwest Oncology Group trial. J. Clin. Oncol. 2001, 19, 3210–3218. [PUBMED], [INFOTRIEVE]
- Huisman, C.; Smit, E F.; Giaccone, G.; Postmus, P E. Second-line chemotherapy in relapsing or refractory non-small-cell lung cancer: a review. J. Clin. Oncol. 2000, 18, 3722–3730. [PUBMED], [INFOTRIEVE]
- Adonizio, C S.; Babb, J S.; Maiale, C.; , et al. Temozolomide in non-small-cell lung cancer: preliminary results of a phase II trial in previously treated patients. Clin. Lung Cancer 2002, 3, 254–258. [PUBMED], [INFOTRIEVE]
- Newlands, E S.; Blackledge, G R.; Slack, J A.; , et al. Phase I trial of temozolomide (CCRG 81045: M&B 39831: NSC 362856). Br. J. Cancer 1992, 65, 287–291. [PUBMED], [INFOTRIEVE]
- Stupp, R.; Ostermann, S.; Leyvraz, S.; Csajka, C.; Buclin, T.; Decosterd, L A. Cerebrospinal fluid levels of temozolomide as a surrogate marker for brain penetration [abstract]. Proc. Am. Soc. Clin. Oncol. 2001, 20, 59a.
- Yung, W K.; Prados, M D.; Yaya-Tur, R.; , et al. Multicenter phase II trial of temozolomide in patients with anaplastic astrocytoma or anaplastic oligoastrocytoma at first relapse. J. Clin. Oncol. 1999, 17, 2762–2771. [PUBMED], [INFOTRIEVE]
- Yung, W K.; Albright, R E.; Olson, J.; , et al. A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapse. Br. J. Cancer 2000, 83, 588–593. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Loeffler, J S.; Patchell, R A.; Sawaya, R. Treatment of metastatic cancer. In Cancer: Principles and Practice of Oncology5th Ed.; DeVita, V T.J., Hellman, S., Rosenberg, S A., Eds.; Lippincott-Raven Publishers: Philadelphia, PA, 1997; 2523–2536.
- Christodoulou, C.; Bafaloukos, D.; Kosmidis, P.; , et al. Phase II study of temozolomide in heavily pretreated cancer patients with brain metastases. Ann. Oncol. 2001, 12, 249–254. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Antonadou, D.; Paraskevaidis, M.; Sarris, G.; , et al. Phase II randomized trial of temozolomide and concurrent radiotherapy in patients with brain metastases. J. Clin. Oncol. 2002, 20, 3644–3650. [PUBMED], [INFOTRIEVE], [CROSSREF]
- American Cancer Society. Cancer Facts and Figures 2002; American Cancer Society: Atlanta, GA, 2002
- Greenlee, R T.; Murray, T.; Bolden, S.; Wingo, P A. Cancer statistics, 2000. CA Cancer J. Clin. 2000, 50, 7–33. [PUBMED], [INFOTRIEVE], [CSA]
- Clark, R.; Ihde, D C. Small-cell lung cancer: treatment progress and prospects. Oncology (Huntingt.) 1998, 12, pp. 647–658, 661–663.
- Shepherd, FA. Chemotherapy for advanced non-small-cell lung cancer: modest progress, many choices. J. Clin. Oncol. 2000, 18, 35S–38S. [PUBMED], [INFOTRIEVE]
- Schiller, J H.; Harrington, D.; Belani, C P.; , et al. Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer. N. Engl. J. Med. 2002, 346, 92–98. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Su, Y B.; Sejean, S.; Krown, S E.; Livingston, P O.; Wolchok, J D.; Quinn, C.; Williams, L.; Foster, T.; Sepkowitz, K A.; Chapman, P B. Selective CD4 + lymphopenia in melanoma patients treated with temozolomide: a toxicity with therapeutic implications. J. Clin. Oncol. 2004, 22, 610–616. [PUBMED], [INFOTRIEVE], [CROSSREF]